{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:09:37Z","timestamp":1766167777209,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03595-2","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:12:51Z","timestamp":1748797971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EZH2 expression in corneal and conjunctival intraepithelial neoplasia and squamous cell carcinoma: a potential marker for diagnosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Huanhuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuangling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,1]]},"reference":[{"key":"3595_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000538174","volume":"10","author":"T Kalas","year":"2024","unstructured":"Kalas T, Vagenas D, Maccheron L et al (2024) Clinicopathological Correlates of Ocular Surface Squamous Neoplasia. Ocul Oncol Pathol 10:88\u201397. https:\/\/doi.org\/10.1159\/000538174","journal-title":"Ocul Oncol Pathol"},{"issue":"suppl 1","key":"3595_CR2","doi-asserted-by":"publisher","first-page":"e2024S124","DOI":"10.1590\/1806-9282.2024s124","volume":"70","author":"A Novelli","year":"2024","unstructured":"Novelli A, Romero-Kusabara IL, Fraz\u00e3o M (2024) Update in ocular surface squamous neoplasia. Rev Assoc M\u00e9d Bras 70(suppl 1):e2024S124. https:\/\/doi.org\/10.1590\/1806-9282.2024s124","journal-title":"Rev Assoc M\u00e9d Bras"},{"issue":"3","key":"3595_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41433-022-01955-1","volume":"37","author":"S Kaliki","year":"2023","unstructured":"Kaliki S, Wagh RD, Vempuluru VS et al (2023) Ocular surface squamous neoplasia with orbital tumour extension: risk factors and outcomes. Eye (London) 37(3):446\u2013452. https:\/\/doi.org\/10.1038\/s41433-022-01955-1","journal-title":"Eye (London)"},{"issue":"1","key":"3595_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40135-020-00260-y","volume":"9","author":"U Patel","year":"2021","unstructured":"Patel U, Karp CL, Dubovy SR (2021) Update on the management of ocular surface squamous neoplasia. Curr Ophthalmol Rep 9(1):7\u201315. https:\/\/doi.org\/10.1007\/s40135-020-00260-y","journal-title":"Curr Ophthalmol Rep"},{"issue":"2","key":"3595_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188700","volume":"1877","author":"S Sun","year":"2022","unstructured":"Sun S, Yu F, Xu D et al (2022) EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy. Biochim Biophys Acta Rev Cancer 1877(2):188700. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188700","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3595_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14576","author":"M Sabour-Takanlou","year":"2024","unstructured":"Sabour-Takanlou M, Sabour-Takanlou L, Biray-Avci C (2024) EZH2-associated tumor malignancy: a prominent target for cancer treatment. Clin Genet 106(4):377\u2013385.\u00a0https:\/\/doi.org\/10.1111\/cge.14576","journal-title":"Clin Genet"},{"issue":"6","key":"3595_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12032-023-02025-6","volume":"40","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang Q (2023) The roles of EZH2 in cancer and its inhibitors. Med Oncol 40(6):167. https:\/\/doi.org\/10.1007\/s12032-023-02025-6","journal-title":"Med Oncol"},{"issue":"3","key":"3595_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36946","volume":"15","author":"A Priya","year":"2023","unstructured":"Priya A, Chaurasia JK, K P et al (2023) Evaluation of immunohistochemical expression of enhancer of zeste homolog 2 (EZH2) and its association with clinicopathological variables in carcinoma cervix. Cureus 15(3):e36946. https:\/\/doi.org\/10.7759\/cureus.36946","journal-title":"Cureus"},{"issue":"10","key":"3595_CR9","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.3390\/ijms25105250","volume":"25","author":"M Revesz","year":"2024","unstructured":"Revesz M, Oberna F, Slezak A et al (2024) EZH2 expression in head-and-neck squamous cell cancer in young patients. Int J Mol Sci 25(10):5250. https:\/\/doi.org\/10.3390\/ijms25105250","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3595_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1159\/000531530","volume":"66","author":"Z Lin","year":"2023","unstructured":"Lin Z, Tang L, Chen S et al (2023) EZH2 expression in retinoblastoma: a potential therapeutic target. Ophthalmic Res 66(1):1014\u20131019. https:\/\/doi.org\/10.1159\/000531530","journal-title":"Ophthalmic Res"},{"key":"3595_CR11","doi-asserted-by":"publisher","first-page":"1213426","DOI":"10.3389\/fonc.2023.1213426","volume":"13","author":"P Julius","year":"2023","unstructured":"Julius P, Siyumbwa SN, Maate F et al (2023) Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target. Front Oncol 13:1213426. https:\/\/doi.org\/10.3389\/fonc.2023.1213426","journal-title":"Front Oncol"},{"key":"3595_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4103\/IJO.IJO_909_24","volume":"73","author":"PVT Prasad","year":"2025","unstructured":"Prasad PVT, Krishnan SR, Radhakrishnan N et al (2025) OSSN in South India: Clinical presentation, treatment outcomes, and histopathologic correlations. Indian J Ophthalmol 73(4):586\u2013589. https:\/\/doi.org\/10.4103\/IJO.IJO_909_24","journal-title":"Indian J Ophthalmol"},{"key":"3595_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-030-18757-6-6","volume-title":"Surgical ophthalmic oncology","author":"R Rao","year":"2019","unstructured":"Rao R, Shields CL (2019) Overview and classification of conjunctival and corneal tumors. In: Chaugule S, Honavar S, Finger P (eds) Surgical ophthalmic oncology. Springer, Cham, pp 63\u201379. https:\/\/doi.org\/10.1007\/978-3-030-18757-6-6"},{"issue":"5","key":"3595_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jclinpath-2020-207302","volume":"75","author":"A Reese","year":"2022","unstructured":"Reese A, Margo CE (2022) Conjunctival squamous intraepithelial neoplasia and its differential diagnosis. J Clin Pathol 75(5):354\u2013358. https:\/\/doi.org\/10.1136\/jclinpath-2020-207302","journal-title":"J Clin Pathol"},{"key":"3595_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251337166","author":"X Lan","year":"2025","unstructured":"Lan X, Xie Z, Fang X et al (2025) Ocular surface squamous neoplasia: Growth, diagnosis, and treatment. Eur J Ophthalmol. Published online Apr 24:11206721251337166. https:\/\/doi.org\/10.1177\/11206721251337166","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3595_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.18240\/ijo.2025.01.16","volume":"18","author":"ME. S. Diaz","year":"2025","unstructured":"Diaz ME S, Lim Bon Siong R, Yao JA et al (2025) Clinical profile and outcomes of ocular surface squamous neoplasia at the Philippine General Hospital: a retrospective study. Int J Ophthalmol 18(1):132\u2013138. https:\/\/doi.org\/10.18240\/ijo.2025.01.16","journal-title":"International journal of ophthalmology"},{"issue":"1","key":"3595_CR17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/11206721211007109","volume":"32","author":"VS Vempuluru","year":"2022","unstructured":"Vempuluru VS, Pattnaik M, Ghose N et al (2022) Bilateral ocular surface squamous neoplasia: a study of 25 patients and review of literature. Eur J Ophthalmol 32(1):620\u2013627. https:\/\/doi.org\/10.1177\/11206721211007109","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"3595_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/pin.13093","volume":"71","author":"IS Genco","year":"2021","unstructured":"Genco IS, Hackman K, Morrar D et al (2021) The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast. Pathol Int 71(6):415\u2013419. https:\/\/doi.org\/10.1111\/pin.13093","journal-title":"Pathol Int"},{"issue":"2","key":"3595_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/EGJP.EGJP_48_19","volume":"39","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Tharwat S, Mohammad AE et al (2019) Overexpression of cytokeratin 17 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Egyptian Journal of Pathology 39(2):299. https:\/\/doi.org\/10.4103\/EGJP.EGJP_48_19","journal-title":"Egyptian Journal of Pathology"},{"issue":"4","key":"3595_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00428-021-03132-3","volume":"479","author":"M Sasaki","year":"2021","unstructured":"Sasaki M, Sato Y (2021) An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy. Virchows Archiv: Int J Pathol 479(4):697\u2013703. https:\/\/doi.org\/10.1007\/s00428-021-03132-3","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"2","key":"3595_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-011-1591-2","volume":"132","author":"SH Alford","year":"2012","unstructured":"Alford SH, Toy K, Merajver SD et al (2012) Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Res Treat 132(2):429\u2013437. https:\/\/doi.org\/10.1007\/s10549-011-1591-2","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3595_CR22","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00417-020-04734-4","volume":"258","author":"S Nuessle","year":"2020","unstructured":"Nuessle S, Soriano D, Boehringer D et al (2020) HIF-1alpha, HIF-2alpha, and ProExC: diagnostic or prognostic relevance in conjunctival intraepithelial neoplasia?.Graefes Arch Clin Exp Ophthalmol 258:2023\u20132030. https:\/\/doi.org\/10.1007\/s00417-020-04734-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"3595_CR23","doi-asserted-by":"publisher","first-page":"e1483","DOI":"10.1111\/aos.14844","volume":"99","author":"S Chauhan","year":"2021","unstructured":"Chauhan S, Sen S, Chauhan SS et al (2021) Stratifin in ocular surface squamous neoplasia and its association with p53. Acta Ophthalmol 99(8):e1483\u2013e1491. https:\/\/doi.org\/10.1111\/aos.14844","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"3595_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/path.2345","volume":"215","author":"M Sasaki","year":"2008","unstructured":"Sasaki M, Yamaguchi J, Itatsu K et al (2008) Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol 215(2):175\u2013183. https:\/\/doi.org\/10.1002\/path.2345","journal-title":"J Pathol"},{"issue":"3","key":"3595_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/his.12016","volume":"62","author":"M Sasaki","year":"2013","unstructured":"Sasaki M, Matsubara T, Yoneda N et al (2013) Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Histopathology 62(3):446\u2013457. https:\/\/doi.org\/10.1111\/his.12016","journal-title":"Histopathology"},{"issue":"3","key":"3595_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/PGP.0b013e31829c6574","volume":"33","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu T, Bao X et al (2014) Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis. Int J Gynecol Pathol 33(3):218\u2013224. https:\/\/doi.org\/10.1097\/PGP.0b013e31829c6574","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"3595_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00417-005-0025-4","volume":"244","author":"C Auw-Haedrich","year":"2006","unstructured":"Auw-Haedrich C, Sundmacher R, Freudenberg N et al (2006) Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol 244(1):96\u2013103. https:\/\/doi.org\/10.1007\/s00417-005-0025-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3595_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/1874364100802010048","volume":"2","author":"C Auw-Haedrich","year":"2008","unstructured":"Auw-Haedrich C, Martin G, Spelsberg H et al (2008) Expression of p16 in conjunctival intraepithelial neoplasia does not correlate with HPV-infection. Open Ophthalmol J 2(1):48\u201356. https:\/\/doi.org\/10.2174\/1874364100802010048","journal-title":"Open Ophthalmol J"},{"issue":"1","key":"3595_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.18231\/j.ijpo.2023.007","volume":"10","author":"S Kepuladze","year":"2023","unstructured":"Kepuladze S, Nikolaishvili N, Chichua G et al (2023) Molecular markers of the progression of conjunctival neoplastic epithelial lesions and its correlation with P16 and HPV expression. Indian J Pathol Oncol 10(1):40\u201343. https:\/\/doi.org\/10.18231\/j.ijpo.2023.007","journal-title":"Indian J Pathol Oncol"},{"issue":"3","key":"3595_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ajcp\/aqw007","volume":"145","author":"P Zoroquiain","year":"2016","unstructured":"Zoroquiain P, Faingold D, Algahmdi S et al (2016) Analysis of HSP90 expression is valuable in the differential diagnosis of ocular surface squamous lesions. Am J Clin Pathol 145(3):385\u2013392. https:\/\/doi.org\/10.1093\/ajcp\/aqw007","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"3595_CR31","doi-asserted-by":"publisher","first-page":"93164","DOI":"10.1371\/journal.pone.0093164","volume":"9","author":"M Nagata","year":"2014","unstructured":"Nagata M, Nakamura T, Sotozono C et al (2014) LRIG1 as a Potential Novel Marker for Neoplastic Transformation in Ocular Surface Squamous Neoplasia. PLoS ONE 9(4):e93164. https:\/\/doi.org\/10.1371\/journal.pone.0093164","journal-title":"PLoS ONE"},{"key":"3595_CR32","doi-asserted-by":"publisher","first-page":"1611547","DOI":"10.3389\/pore.2023.1611547","volume":"29","author":"E Makk","year":"2023","unstructured":"Makk E, Bohonyi N, Oszter A et al (2023) Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas. Pathol Oncol Res 29:1611547. https:\/\/doi.org\/10.3389\/pore.2023.1611547","journal-title":"Pathol Oncol Res"},{"key":"3595_CR33","doi-asserted-by":"publisher","first-page":"1438021","DOI":"10.3389\/fonc.2024.1438021","volume":"14","author":"CV Valea","year":"2025","unstructured":"Valea CV, Klein M, Hallermann C et al (2025) EZH2: an analysis of a potential new tumormarker in high-risk localization of cutaneous squamous cell carcinomas. Front Oncol 14:1438021. https:\/\/doi.org\/10.3389\/fonc.2024.1438021","journal-title":"Front Oncol"},{"issue":"1","key":"3595_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W (2020) EZH2: a novel target for cancer treatment. J Hematol Oncol 13(1):104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3595_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/ICO.0000000000003461","volume":"43","author":"JA Greenfield","year":"2024","unstructured":"Greenfield JA, Cohen AK, Galor A et al (2024) Ocular surface squamous neoplasia: changes in the standard of care 2003 to 2022. Cornea 43(8):94\u2013943. https:\/\/doi.org\/10.1097\/ICO.0000000000003461","journal-title":"Cornea"},{"issue":"8","key":"3595_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237453","volume":"15","author":"R H\u00f6llhumer","year":"2020","unstructured":"H\u00f6llhumer R, Williams S, Michelow P (2020) Observational study of ocular surface squamous neoplasia: risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa. PLoS ONE 15(8):e0237453. https:\/\/doi.org\/10.1371\/journal.pone.0237453","journal-title":"PLoS ONE"},{"key":"3595_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000842","volume":"6","author":"OP Alvarez","year":"2021","unstructured":"Alvarez OP, Zein M, Galor A et al (2021) Management of ocular surface squamous neoplasia: Bowman club lecture 2021. BMJ Open Ophthalmol 6:e000842. https:\/\/doi.org\/10.1136\/bmjophth-2021-000842","journal-title":"BMJ Open Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03595-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03595-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03595-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:39Z","timestamp":1766167539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03595-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3595"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03595-2","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Medical Ethics Review Board of Zhongshan Ophthalmic Center, Sun Yat-sen University (approval number: 2024KYPJ130) and conducted in accordance with ethical standards stated in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"219"}}